China Gastric Cancer Drugs Market (2025-2031) | Analysis, Growth, Competitive, Competition, Strategic Insights, Size, Companies, Opportunities, Consumer Insights, Revenue, Supply, Pricing Analysis, Segmentation, Value, Forecast, Challenges, Restraints, Investment Trends, Trends, Outlook, Demand, Strategy, Share, Industry, Segments, Drivers

Market Forecast By Disease Type (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor), By Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy), By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists), By Route of Administration (Oral, Injectable), By Distribution Channel (Specialty and Retail Pharmacies, Others, Hospital Pharmacies) And Competitive Landscape
Product Code: ETC12222021 Publication Date: Apr 2025 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 65 No. of Figures: 34 No. of Tables: 19

Key Highlights of the Report:

  • China Gastric Cancer Drugs Market Outlook
  • Market Size of China Gastric Cancer Drugs Market,2024
  • Forecast of China Gastric Cancer Drugs Market, 2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Revenues & Volume for the Period 2021-2031
  • China Gastric Cancer Drugs Market Trend Evolution
  • China Gastric Cancer Drugs Market Drivers and Challenges
  • China Gastric Cancer Drugs Price Trends
  • China Gastric Cancer Drugs Porter's Five Forces
  • China Gastric Cancer Drugs Industry Life Cycle
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Disease Type for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Adenocarcinoma for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Lymphoma for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Gastrointestinal Stromal Tumor for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Treatment Type for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Immunotherapy for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Targeted Therapy for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Chemotherapy for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Drug Class for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By PD-1/PD-L1 Inhibitors for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By HER2 Antagonists for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By VEGFR2 Antagonists for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Route of Administration for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Oral for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Injectable for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Distribution Channel for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Specialty and Retail Pharmacies for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Others for the Period 2021-2031
  • Historical Data and Forecast of China Gastric Cancer Drugs Market Revenues & Volume By Hospital Pharmacies for the Period 2021-2031
  • China Gastric Cancer Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Disease Type
  • Market Opportunity Assessment By Treatment Type
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Channel
  • China Gastric Cancer Drugs Top Companies Market Share
  • China Gastric Cancer Drugs Competitive Benchmarking By Technical and Operational Parameters
  • China Gastric Cancer Drugs Company Profiles
  • China Gastric Cancer Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the China Gastric Cancer Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the China Gastric Cancer Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 China Gastric Cancer Drugs Market Overview

3.1 China Country Macro Economic Indicators

3.2 China Gastric Cancer Drugs Market Revenues & Volume, 2021 & 2031F

3.3 China Gastric Cancer Drugs Market - Industry Life Cycle

3.4 China Gastric Cancer Drugs Market - Porter's Five Forces

3.5 China Gastric Cancer Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.6 China Gastric Cancer Drugs Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F

3.7 China Gastric Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.8 China Gastric Cancer Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 China Gastric Cancer Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 China Gastric Cancer Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of gastric cancer in China

4.2.2 Growing awareness and early diagnosis of gastric cancer

4.2.3 Advances in medical technology and treatment options for gastric cancer

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval in China

4.3.2 High cost of cancer drugs and treatment

4.3.3 Limited access to healthcare services in rural areas of China

5 China Gastric Cancer Drugs Market Trends

6 China Gastric Cancer Drugs Market, By Types

6.1 China Gastric Cancer Drugs Market, By Disease Type

6.1.1 Overview and Analysis

6.1.2 China Gastric Cancer Drugs Market Revenues & Volume, By Disease Type, 2021 - 2031F

6.1.3 China Gastric Cancer Drugs Market Revenues & Volume, By Adenocarcinoma, 2021 - 2031F

6.1.4 China Gastric Cancer Drugs Market Revenues & Volume, By Lymphoma, 2021 - 2031F

6.1.5 China Gastric Cancer Drugs Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021 - 2031F

6.1.6 China Gastric Cancer Drugs Market Revenues & Volume, By Carcinoid Tumor, 2021 - 2031F

6.1.7 China Gastric Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F

6.2 China Gastric Cancer Drugs Market, By Treatment Type

6.2.1 Overview and Analysis

6.2.2 China Gastric Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F

6.2.3 China Gastric Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F

6.2.4 China Gastric Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F

6.2.5 China Gastric Cancer Drugs Market Revenues & Volume, By Radiation Therapy and Surgery, 2021 - 2031F

6.3 China Gastric Cancer Drugs Market, By Drug Class

6.3.1 Overview and Analysis

6.3.2 China Gastric Cancer Drugs Market Revenues & Volume, By PD-1/PD-L1 Inhibitors, 2021 - 2031F

6.3.3 China Gastric Cancer Drugs Market Revenues & Volume, By HER2 Antagonists, 2021 - 2031F

6.3.4 China Gastric Cancer Drugs Market Revenues & Volume, By VEGFR2 Antagonists, 2021 - 2031F

6.3.5 China Gastric Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F

6.4 China Gastric Cancer Drugs Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 China Gastric Cancer Drugs Market Revenues & Volume, By Oral, 2021 - 2031F

6.4.3 China Gastric Cancer Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F

6.5 China Gastric Cancer Drugs Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 China Gastric Cancer Drugs Market Revenues & Volume, By Specialty and Retail Pharmacies, 2021 - 2031F

6.5.3 China Gastric Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F

6.5.4 China Gastric Cancer Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F

7 China Gastric Cancer Drugs Market Import-Export Trade Statistics

7.1 China Gastric Cancer Drugs Market Export to Major Countries

7.2 China Gastric Cancer Drugs Market Imports from Major Countries

8 China Gastric Cancer Drugs Market Key Performance Indicators

8.1 Patient survival rates post-treatment

8.2 Adoption rate of innovative treatment options

8.3 Number of clinical trials for gastric cancer drugs in China

9 China Gastric Cancer Drugs Market - Opportunity Assessment

9.1 China Gastric Cancer Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.2 China Gastric Cancer Drugs Market Opportunity Assessment, By Treatment Type, 2021 & 2031F

9.3 China Gastric Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.4 China Gastric Cancer Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 China Gastric Cancer Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 China Gastric Cancer Drugs Market - Competitive Landscape

10.1 China Gastric Cancer Drugs Market Revenue Share, By Companies, 2024

10.2 China Gastric Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All